Traffic:
10E
10W
15N
15S
57N
57S
60E
60W
210E
210W
This Site
Web Search
powered by
YAHOO! SEARCH
Subscriber Services
|
Home Delivery
|
e-Edition
|
Alerts
|
RSS
Home
News
Ontario
Rancho Cucamonga
Pomona
Upland
Claremont
Montclair
Chino Valley
California
Crime & Public Safety
Elections
Education
S.B. County Watch
Upland Watch
I.E.: Medicare Testing Ground
Sports
Buy Event Tickets Now
Golf - Tee Times and Courses
Preps
Reign Hockey
Rancho Cucamonga Quakes
Local Colleges
USC
UCLA
Lakers
Clippers
Dodgers
Angels
Ducks
Soccer
Motor Sports
Horse Racing
Live Odds
Business
Autos
Real Estate News
Technology
Opinions
Editorial
Letters
Columnists
Blogs
LA.COM
Buy Tickets
Movies
TV
Music
Shopping & Beauty
Recreation
Neighborhood
Arts
Living
Dining
Find A Restaurant
Lottery
Horoscopes
Travel
Trevor's Travels
Health
Crossword Puzzle
Local Casinos
Foothills Magazine
Info
Subscribe For Home Delivery
Contact Us
RSS
Podcast
Subscriber Services
Place An Ad
NIE
Classified
Place an Ad
Homes
Jobs
Auto
Search autos
Buy/Sell a car
Research/Financing a car
Find a dealer
Shopping
This week's ads
Obits
Directories
Local Business
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Clearside Biomedi
(NQ:
CLSD
)
1.305
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
1.305
Bid (Size)
1.230 (6)
Ask (Size)
1.390 (12)
Prev. Close
1.305
Today's Range
1.305 - 1.305
52wk Range
0.6501 - 2.120
Shares Outstanding
61,666,130
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
CLSD Stock Earnings: Clearside Biomedical Beats EPS, Misses Revenue for Q2 2024
August 12, 2024
CLSD stock results show that Clearside Biomedical beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Why Is Clearside Biomedical Stock Gaining Today?
June 25, 2024
Clearside Biomedical pioneers suprachoroidal drug delivery for precise, effective treatment of retinal diseases. Oppenheimer rates CLSD Outperform with a $5 target, citing its innovative SCS...
Via
Benzinga
Performance
YTD
+1.16%
+1.16%
1 Month
+27.94%
+27.94%
3 Month
+16.52%
+16.52%
6 Month
-19.94%
-19.94%
1 Year
+53.71%
+53.71%
More News
Read More
12 Health Care Stocks Moving In Wednesday's After-Market Session
May 22, 2024
Via
Benzinga
Clearside Biomedical And 3 Other Penny Stocks Insiders Are Buying
May 16, 2024
Via
Benzinga
CLSD Stock Earnings: Clearside Biomedical Misses EPS, Misses Revenue for Q1 2024
May 09, 2024
Via
InvestorPlace
Clearside Biomedical: Q4 Earnings Insights
March 12, 2024
Via
Benzinga
Preview: Clearside Biomedical's Earnings
March 11, 2024
Via
Benzinga
Clearside Biomedical: Q3 Earnings Insights
November 13, 2023
Via
Benzinga
Clearside Biomedical's Earnings: A Preview
November 10, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
May 09, 2024
Via
Benzinga
3 Penny Stocks That Insiders Are Buying
May 07, 2024
Via
MarketBeat
Expensify And 2 Other Stocks Under $2 Insiders Are Buying
April 22, 2024
Via
Benzinga
7 Top Stocks Under $7
April 11, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
March 27, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
March 14, 2024
Via
Benzinga
Earnings Scheduled For March 12, 2024
March 12, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
March 11, 2024
Via
Benzinga
7 Biotech Penny Stocks on the Verge of Clinical Trial Victory
February 25, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
February 20, 2024
Via
Benzinga
Top 5 Health Care Stocks That May Crash This Month
January 22, 2024
Via
Benzinga
Ocular Gene Therapy: Regenxbio Data Shows Consistent Preservation Of Visual Acuity, Retinal Thickness
January 17, 2024
Via
Benzinga
Earnings Scheduled For November 13, 2023
November 13, 2023
Via
Benzinga
Over $2M Bet On Community Health Systems? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
November 02, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
3 Cheap Stocks to Buy Under $1 in October 2023
October 26, 2023
Via
InvestorPlace
Week In Review: QYuns Plans Hong Kong IPO For Autoimmune/Allergic Disease Portfolio
October 07, 2023
Via
Talk Markets
Topics
Initial Public Offering
Exposures
Securities Market
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Privacy Policy
|
Terms of Use
|
MNG Corporate Site Map
|
Copyright